Stryker (SYK) Long-Term Deferred Tax (2009 - 2026)
Stryker's (SYK) quarterly Long-Term Deferred Tax came in at $994.0 million in Q2 2026, down 27.71% year-over-year from $1.4 billion in Q2 2025, and down 16.68% quarter-over-quarter from $1.2 billion in Q1 2026.
Analysis
Stryker (SYK) Long-Term Deferred Tax (2009 - 2026) Analysis & Trends
Stryker (SYK) has reported Long-Term Deferred Tax for 16 consecutive years, with $994.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Long-Term Deferred Tax fell 27.71% year-over-year to $994.0 million in Q2 2026; TTM through Jun 2026 was $994.0 million, a 27.71% decrease from a year earlier, with the FY2025 full-year figure at $1.1 billion, down 36.97% from the prior year.
- Long-Term Deferred Tax was $994.0 million for Q2 2026 at Stryker, down from $1.2 billion in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $1.7 billion in Q4 2024 and troughed at $994.0 million in Q2 2026.
- A 5-year average of $1.4 billion and a median of $1.4 billion in 2023 frame the typical range for Long-Term Deferred Tax.
- Across the five-year window, Long-Term Deferred Tax rose 18.44% in 2023 and plunged 36.97% in 2025, its largest moves.
- Over 5 years, Long-Term Deferred Tax stood at $1.4 billion in 2022, then increased by 18.44% to $1.7 billion in 2023, then increased by 4.31% to $1.7 billion in 2024, then sank by 36.97% to $1.1 billion in 2025, then slipped by 9.47% to $994.0 million in 2026.
- The last three Long-Term Deferred Tax figures came in at $994.0 million (Q2 2026), $1.2 billion (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 17.73 Bn | 17.32 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 994.00 Mn |
| Mar 31, 2026 | 1.19 Bn |
| Dec 31, 2025 | 1.10 Bn |
| Sep 30, 2025 | 1.37 Bn |
| Jun 30, 2025 | 1.38 Bn |
| Mar 31, 2025 | 1.41 Bn |
| Dec 31, 2024 | 1.74 Bn |
| Sep 30, 2024 | 1.56 Bn |
| Jun 30, 2024 | 1.61 Bn |
| Mar 31, 2024 | 1.64 Bn |
| Dec 31, 2023 | 1.67 Bn |
| Sep 30, 2023 | 1.41 Bn |
| Jun 30, 2023 | 1.44 Bn |
| Mar 31, 2023 | 1.44 Bn |
| Dec 31, 2022 | 1.41 Bn |
| Sep 30, 2022 | 1.39 Bn |
| Jun 30, 2022 | 1.63 Bn |
| Mar 31, 2022 | 1.60 Bn |
| Dec 31, 2021 | 1.76 Bn |
| Sep 30, 2021 | 1.86 Bn |